Why Alzheimer’s Drug Sales Are Set to Surge: Three Key Insights for Biotech Investors
Alzheimer's drug sales are gaining momentum as Leqembi and Kisunla expand globally and new P-Tau blood tests transform diagnosis. Here's what biotech investors need to know.
Read this issue